Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care | WSJ

12 total views
Hundreds of clinics specializing in ketamine treatment for depression and other mood disorders have popped up in the U.S. in recent years. WSJ visits one clinic, Nushama, to learn why some entrepreneurs are betting that demand for ketamine will continue to rise.

Photo illustration: Laura Kammermann/WSJ

More from the Wall Street Journal:
Visit the WSJ Video Center:

On Facebook:
On Twitter:
On Snapchat:

#Ketamine #Healthcare #WSJ

Share this Post